Eliisa Löyttyniemi
eliisa.loyttyniemi@utu.fi +358 29 450 4450 +358 50 308 2458 Kiinamyllynkatu 10 Turku |
Areas of expertise
Teaching and consulting biostatistics, and analysing all kind of datasets
Teaching and consulting biostatistics, and analysing all kind of datasets
Research
Biostatistics especially in clinical trials
Biostatistics especially in clinical trials
Publications
- A PET Tracer for Brain α2C Adrenoceptors, 11C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice (2014)
- Journal of Nuclear Medicine
(A1 Refereed original research article in a scientific journal) - Cdc20 and securin overexpression predict short-term breast cancer survival (2014)
- British Journal of Cancer
(A1 Refereed original research article in a scientific journal) - Evaluation of repeated [18F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas (2014)
- EJNMMI Research
(A1 Refereed original research article in a scientific journal) - Moderate Intensity Training Has More Desirable Effects on Liver Metabolism than High-Intensity Interval Training in Healthy, Sedentary, and Middle-aged Men (2014)
- Diabetes
(Other publication) - Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project (2014)
- European Psychiatry
(A1 Refereed original research article in a scientific journal) - Trends of weekly musculoskeletal pain from 2000 to 2012: National study of Finnish university students. (2014)
- European Journal of Pain
(A1 Refereed original research article in a scientific journal) - Uptake of [18F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma (2014)
- Translational Oncology
(A1 Refereed original research article in a scientific journal) - Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women (2013)
- Osteoporosis International
(A1 Refereed original research article in a scientific journal) - Intermittent megadose treatment with vitamin D3 is not optimal to keep serum 25OHD levels at or over the target of 75 nmol/L (2013)
- Osteoporosis International
(A1 Refereed original research article in a scientific journal) - The effectiveness of teriparatide in the clinical practice-attenuation of the bone mineral density outcome by increasing age and bisphosphonate pretreatment (2013)
- Annals of Medicine
(A1 Refereed original research article in a scientific journal)



